Apicomplexan phosphodiesterases in cyclic nucleotide turnover: conservation, function, and therapeutic potential

Area of Science:

• Parasitology
• Molecular Biology
• Biochemistry

Background:

• Apicomplexa are significant intracellular parasites affecting various animals.
• Cyclic nucleotide signaling pathways involving cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP) are vital for apicomplexan parasites.
• Conserved cyclases and kinases manage cyclic nucleotide levels, while phosphodiesterases (PDEs) hydrolyze them, regulating signaling.

Purpose of the Study:

• To review recent advancements in apicomplexan PDE biology.
• To explore therapeutic intervention opportunities targeting PDEs in key human apicomplexan parasites.
• To highlight the diversity and conserved functions of PDEs across different apicomplexan genera and life stages.

Main Methods:

• Literature review of current research on apicomplexan PDEs.
• Comparative analysis of PDE repertoires across genera like Plasmodium, Toxoplasma, Cryptosporidium, and Babesia.
• Discussion of conserved cellular roles of PDEs in parasite motility, host cell egress, and invasion.

Main Results:

• Apicomplexan PDEs exhibit a highly flexible repertoire, adapting to diverse cellular needs across various species and life stages.
• Despite phylogenetic diversity, essential PDE functions in parasite motility, host cell egress, and invasion are conserved.
• The adaptable molecular regulation of PDEs suggests redundancy and diversity are crucial for optimizing cyclic nucleotide turnover.

Conclusions:

• Apicomplexan PDE biology is complex, with significant diversity and conserved functions.
• Targeting PDEs presents a promising avenue for developing novel therapeutics against apicomplexan infections.
• Further research into PDE regulation and integration with other signaling pathways is warranted for therapeutic development.